Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer.
Medical Oncology Department, MUHC Royal Victoria Hospital, 687 Pine Avenue West, Suite A3.04, Montreal, Quebec H3A 1A1,  vera.hirsh@muhc.mcgill.ca.
Vera
V
Hirsh